Atlas Trials

Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)

Clinical trial NCT04952337 · UNKNOWN

Trial details

NCT number
NCT04952337
Sponsor
Hannover Medical School
Status
UNKNOWN
Study type
OBSERVATIONAL
COVID-19Viral PneumoniaPneumonia Due to Streptococcus PneumoniaeBacterial PneumoniaPneumonia Due to H. InfluenzaePneumonia, Organism UnspecifiedPneumonia in Diseases Classified ElsewherePneumonia Due to Other Specified Infectious Organisms
Start date
2020-10-01
Primary completion
2022-01-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.